Partner Content Partner Content Hear from Genentech and Cristalia Produtos Quimicos Farmaceu... HPAPI 2018
News Roche and AC Immune's Alzheimer's drug on right track Data suggest high dose used in phase 3 trial is most effective
News Three's a crowd as Tecentriq approved in lung cancer Cancer immunotherapy approved in second line.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
